Status:
COMPLETED
Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Aging (NIA)
The Greenwall Foundation
Conditions:
Heart Failure
End-stage Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The primary aim of the study is to provide "proof of concept" to demonstrate that patients with Ventricular Assist Devices (VADs) and caregivers are willing to be enrolled in a randomized trial of pal...
Detailed Description
A ventricular assist device is an implanted mechanical device which augments the pumping function of the heart's ventricles. The number of patients with VADs is expected to increase in an exponential ...
Eligibility Criteria
Inclusion
- age \>21 years
- fluent in English
- have a caregiver/family member who is willing to be enrolled and who is also fluent in English
- consistent and reliable access to a phone
Exclusion
- non English-speaking
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01427634
Start Date
July 1 2011
End Date
July 1 2012
Last Update
September 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029